niacin

Jubilant Cadista Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 20, 2019
Approval ID: cf57262f-2314-31a3-e478-d927a91a11b9
Products: 3 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NIACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NIACIN EXTENDED-RELEASE TABLETS. NIACIN extended-release tablets, for oral use. Initial U.S. Approval: 1997

Quick Stats

Total Products3

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.